Andrei V. Pisliakov

Andrei V. Pisliakov

Auto-generated profile, based on publicly available information

Andrei V. Pisliakov

Computational Biology, School of Life Sciences, University of Dundee

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2007 in Journal of Chemical Theory and Computation
Verified
Journal Article
Closed access
AWArieh Warshel
Arieh Warshel
MKMitsunori Kato
Mitsunori Kato
APAndrei V. Pisliakov
Andrei V. Pisliakov

13 October 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
APAndrei V. Pisliakov
Andrei V. Pisliakov
JCJie Cao
Jie Cao
SKShina Caroline Lynn Kamerlin
Shina Caroline Lynn Kamerlin
AWArieh Warshel
Arieh Warshel
The idea that enzymes catalyze reactions by dynamical coupling between the conformational motions and the chemical coordinates has recently attracted major experimental and theoretical interest. However, experimental studies have not directly established that the conformational motions transfer energy to the chemical coordinate, and simulating enzyme catalysis on the relevant timescales has been impractical. Here, we introduce a renormalization approach that transforms the energetics and dynamics of the enzyme to an equivalent low-dimensional system, and allows us to simulate the dynamical coupling on a ms timescale. The simulations establish, by means of several independent approaches, that the conformational dynamics is not remembered during the chemical step and does not contribute significantly to catalysis. Nevertheless, the precise nature of this coupling is a question of great importance.

20 March 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
BBBeatriz Baragaña
Beatriz Baragaña
BFBarbara Forte
Barbara Forte
RCRyan Choi
Ryan Choi
SHStephen Nakazawa Hewitt
Stephen Nakazawa Hewitt
JBJuan A. Bueren-Calabuig
Juan A. Bueren-Calabuig
IGIan H. Gilbert
Ian H. Gilbert
Malaria and cryptosporidiosis, caused by apicomplexan parasites, remain major drivers of global child mortality. New drugs for the treatment of malaria and cryptosporidiosis, in particular, are of high priority; however, there are few chemically validated targets. The natural product cladosporin is active against blood- and liver-stage Plasmodium falciparum and Cryptosporidium parvum in cell-culture studies. Target deconvolution in P. falciparum has shown that cladosporin inhibits lysyl-tRNA synthetase ( Pf KRS1). Here, we report the identification of a series of selective inhibitors of apicomplexan KRSs. Following a biochemical screen, a small-molecule hit was identified and then optimized by using a structure-based approach, supported by structures of both Pf KRS1 and C. parvum KRS ( Cp KRS). In vivo proof of concept was established in an SCID mouse model of malaria, after oral administration (ED 90 = 1.5 mg/kg, once a day for 4 d). Furthermore, we successfully identified an opportunity for pathogen hopping based on the structural homology between Pf KRS1 and Cp KRS. This series of compounds inhibit Cp KRS and C. parvum and Cryptosporidium hominis in culture, and our lead compound shows oral efficacy in two cryptosporidiosis mouse models. X-ray crystallography and molecular dynamics simulations have provided a model to rationalize the selectivity of our compounds for Pf KRS1 and Cp KRS vs. (human) Hs KRS. Our work validates apicomplexan KRSs as promising targets for the development of drugs for malaria and cryptosporidiosis.

15 June 2006 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
MKMitsunori Kato
Mitsunori Kato
APAndrei V. Pisliakov
Andrei V. Pisliakov
AWArieh Warshel
Arieh Warshel

1 July 2012 in Nature
Verified
Journal Article
Open access
PDF file
JLJoseph A. Lyons
Joseph A. Lyons
DADavid Aragao
David Aragao
OSOrla Slattery
Orla Slattery
APAndrei V. Pisliakov
Andrei V. Pisliakov
TSTewfik Soulimane
Tewfik Soulimane
MCMartin Caffrey
Martin Caffrey
The caa3-type cytochrome oxidase structure described here provides insight into the coupling of energy transduction to the complete reduction of oxygen. The X-ray crystal structure of the cytochrome c oxidase caa3 from Thermus thermophilus has been determined at 2.36-ångström resolution. Cytochrome c oxidase is a multisubunit integral membrane protein that functions as the terminal enzyme in the respiratory chain of mitochondria and aerobic prokaryotes. The caa3-type oxidase is covalently tethered to a cytochrome c domain, which is responsible for transferring electrons to the oxidase domain. The structure provides a framework for examining how this integral membrane complex couples energy transduction to the complete reduction of oxygen. Cytochrome c oxidase is a member of the haem copper oxidase superfamily (HCO)1. HCOs function as the terminal enzymes in the respiratory chain of mitochondria and aerobic prokaryotes, coupling molecular oxygen reduction to transmembrane proton pumping. Integral to the enzyme’s function is the transfer of electrons from cytochrome c to the oxidase via a transient association of the two proteins. Electron entry and exit are proposed to occur from the same site on cytochrome c2,3,4. Here we report the crystal structure of the caa3-type cytochrome oxidase from Thermus thermophilus, which has a covalently tethered cytochrome c domain. Crystals were grown in a bicontinuous mesophase using a synthetic short-chain monoacylglycerol as the hosting lipid. From the electron density map, at 2.36 Å resolution, a novel integral membrane subunit and a native glycoglycerophospholipid embedded in the complex were identified. Contrary to previous electron transfer mechanisms observed for soluble cytochrome c, the structure reveals the architecture of the electron transfer complex for the fused cupredoxin/cytochrome c domain, which implicates different sites on cytochrome c for electron entry and exit. Support for an alternative to the classical proton gate characteristic of this HCO class is presented.

22 January 2012 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
YMYushi Matsumoto
Yushi Matsumoto
TTTakehiko Tosha
Takehiko Tosha
APAndrei V Pisliakov
Andrei V Pisliakov
THTomoya Hino
Tomoya Hino
HSHiroshi Sugimoto
Hiroshi Sugimoto
YSYoshitsugu Shiro
Yoshitsugu Shiro